Lorenzo Corsini, PhD
Lorenzo Corsini is the co-CEO and co-founder of PhagoMed, an Austrian biotech startup focused on endolysins and phages as targeted antimicrobials.
Tags
- S. aureus phage therapy: we need further research This week, we learn from David and Lorenzo from BioNTech (formerly PhagoMed) about their experience with phage inhibition of S. aureus phages by plasma and synovial fluid.
- ɛ²-phages: naturally bred high-tech phages which are superior to wild types in critical properties This week, we're featuring a guest blog post by David Sáez and Lorenzo Corsini of PhagoMed; they dive into their recent paper describing how they're breeding phages to be better for therapy using a modified Appelman's protocol.
